Ken Fisher Organon & Co. Transaction History

Fisher Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 12, 2023	BUY	$21.42 - $32.08 $250,057 - $374,501	11,674 New	11,674 $274,000
Q1 2023 May 01, 2023	SELL	$21.42 - $32.08 $90,563 - $135,634	-4,228 Reduced 26.59%	11,674 $275,000
Q4 2022 Feb 03, 2023	SELL	$23.31 - $28.61 $62,867 - $77,161	-2,697 Reduced 14.5%	15,902 $444,000
Q3 2022 Nov 08, 2022	BUY	$23.4 - $34.25 $32,362 - $47,367	1,383 Added 8.03%	18,599 $435,000
Q2 2022 Aug 09, 2022	BUY	$31.66 - $38.9 $7,313 - $8,985	231 Added 1.36%	17,216 $581,000
Q1 2022 May 05, 2022	SELL	$30.45 - $39.36 $109,102 - $141,026	-3,583 Reduced 17.42%	16,985 $593,000
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $91,543 - $118,556	-3,193 Reduced 13.44%	20,568 $626,000
Q3 2021 Oct 26, 2021	SELL	$28.63 - $35.64 $27 Million - $33.6 Million	-943,699 Reduced 97.54%	23,761 $779,000
Q2 2021 Jul 27, 2021	BUY	$28.45 - $38.0 $27.5 Million - $36.8 Million	967,460 New	967,460 $29.3 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.